Dr. Reddy's Laboratories Limited: Malnutrition trials

The registry lists 66 Malnutrition studies with Dr. Reddy's Laboratories Limited as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 66(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed ConditionsCompletedNCT03702855Phase 1
• Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed ConditionsCompletedNCT02322658Phase 1
• Bioavailability Study of Sirolimus Tablets 2 mg Under Fed ConditionCompletedNCT02296762Phase 1
• Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed ConditionCompletedNCT02296723Phase 1
• Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed ConditionCompletedNCT02292069Phase 1
• Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed ConditionCompletedNCT02291341Phase 1
• Lamotrigine Extended-Release Tablets 50 mg Under Fed ConditionCompletedNCT01888757Phase 1
• Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed ConditionCompletedNCT01888328Phase 1
• Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed ConditionCompletedNCT01888263Phase 1
• Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed ConditionCompletedNCT01888224Phase 1
• Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed ConditionCompletedNCT01691469Phase 1
• Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed ConditionCompletedNCT01674517Phase 1
• Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed ConditionCompletedNCT01671722Phase 1
• Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01645423Phase 1
• Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01645410Phase 1
• Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed ConditionCompletedNCT01627847Phase 1
• Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed ConditionsCompletedNCT01621763Phase 1
• Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01581879Phase 1
• Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed ConditionsCompletedNCT01581788Phase 1
• Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed ConditionCompletedNCT01513681Phase 1
• Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed ConditionsCompletedNCT01513057Phase 1
• Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed ConditionsCompletedNCT01512485Phase 1
• Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed ConditionsCompletedNCT01512459Phase 1
• Bioavailability Study of Fluconazole Tablets 200 mg Under Fed ConditionsCompletedNCT01511757Phase 1
• Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed ConditionCompletedNCT01511718Phase 1
• Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed ConditionsCompletedNCT01506791Phase 1
• Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01506063Phase 1
• Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed ConditionsCompletedNCT01505998Phase 1
• Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed ConditionCompletedNCT01504516Phase 1
• Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed ConditionCompletedNCT01503450Phase 1
• Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed StudyCompletedNCT01503424Phase 1
• Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed ConditionsCompletedNCT01372982Phase 1
• Galantamine Bioequivalence Study of Dr. Reddy's Under Fed ConditionCompletedNCT01372306Phase 1
• Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed ConditionsCompletedNCT01314352Phase 1
• Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01286701Phase 1
• Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01283932Phase 1
• Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed ConditionCompletedNCT01170182Phase 1
• Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01167933Phase 1
• Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed ConditionCompletedNCT01166087Phase 1
• Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed ConditionsCompletedNCT01164826Phase 1
• Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed ConditionsCompletedNCT01164800Phase 1
• Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01161147Phase 1
• Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01160068Phase 1
• Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed ConditionsCompletedNCT01155960Phase 1
• Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01155934Phase 1
• Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01149980Phase 1
• Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01149954Phase 1
• Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed ConditionsCompletedNCT01146041Phase 1
• Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed ConditionCompletedNCT01136538Phase 1
• Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed ConditionsCompletedNCT01133483Phase 1
• Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed ConditionCompletedNCT01133457Phase 1
• Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01132352Phase 1
• Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed ConditionsCompletedNCT01132222Phase 1
• Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01132196Phase 1
• Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fed ConditionCompletedNCT01131975Phase 1
• Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01131936Phase 1
• Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed ConditionsCompletedNCT01131767Phase 1
• Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed ConditionsCompletedNCT01066767Phase 1
• Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed ConditionsCompletedNCT01065987Phase 1
• Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed ConditionCompletedNCT01064271Phase 1
• Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed ConditionsCompletedNCT01064180Phase 1
• Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed ConditionCompletedNCT01056627Phase 1
• Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed ConditionCompletedNCT01053689Phase 1
• Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed ConditionCompletedNCT01053338Phase 1
• Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed ConditionsCompletedNCT01052792Phase 1
• Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed ConditionsCompletedNCT01045434Phase 1